Has Ryan Dumas, MD received payments from drug or device companies?

Yes. Drug and device makers reported $78,302 in general payments to Ryan Dumas, MD across 104 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ryan Dumas, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ryan Dumas, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ryan Dumas, MD

Surgery · Houston, TXNPI 1427342922

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $55,225 of the $78,302 with a category attached, or 70.5%. Teleflex LLC accounts for 98.6% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $39,131, more than ten times the $857 reported in 2019. Among surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$78,302in general payments, 2019–2025

Across 104 payments — averaging $752.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Teleflex LLC$77K
Integra Lifesciences Corporation$400
TEI Biosciences Inc$340
Prytime Medical Devices, Inc.$177
Acell, Inc.$117
Abbott$45

What the payments were for

Consulting fees$14,00018%
Speaking & faculty fees$55,22571%
Travel & lodging$7,60010%
Food & beverage$1,4782%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Teleflex LLC	93	$77,223
Integra Lifesciences Corporation	2	$400
TEI Biosciences Inc	5	$340
Prytime Medical Devices, Inc.	1	$177
Acell, Inc.	1	$117
Abbott	2	$45

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$78,302 in reported general payments places this provider in the 95th percentile of 1,830 surgery providers in Texas.

See all surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$20,625

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgery in Houston

James SuliburkHouston$161K
Funda MericHouston$141K
Jonathan StahlHouston$105K
Richard KnightHouston$103K
Tanyaradzwa KajeseHouston$92K
Michael HarkinsTomball$2.7M
Douglas StoddardAustin$1.4M
Steven FassAustin$989K
Vineet ChoudhryAustin$851K
Andy HawthorneRound Rock$843K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →